ICD 2021: Responders to Bimekizumab Maintain High Skin Clearance Rates for Up to 1 Year
Results from three trials were reviewed.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Results from three trials were reviewed.
Only registered members have full access to PracticeUpdate content.